Summary
Updated Aug 31, 2026
Fred Telling is Director of ORAGENICS INC (OGEN). 2 SEC Form 4 filings on record going back to 2024, most recently on 22 January 2026. Most recent open-market trade: sold $198 of OGEN on 22 January 2026. Lifetime open-market sales: $1K.
Recent Transactions
2Every recent SEC Form 4 transaction Fred Telling has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Fred Telling. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Odyssey Health, Inc. - $74K of OGEN open-market activity on record
- Alan W. Dunton - $24 of OGEN open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Fred Telling?
Fred Telling is a corporate insider, tracked as Director of ORAGENICS INC (OGEN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Fred Telling last file a Form 4?
The most recent primary Form 4 on record is dated 22 January 2026, one of 2 filings going back to 2024.
Has Fred Telling been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1K) across all tracked filings.
Where can I see all of Fred Telling's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Fred Telling and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
